Charles River Laboratories, a US specialist provider of laboratory, gene and cell therapy services, has acquired Explora BioLabs for approximately $295 million in cash.
US-based Charles River Laboratories International on Oct. 12 completed the divestment of its gene therapy CDMO site in Sweden and its research models and services...
US CDMO Charles River Laboratories has entered into an agreement to buy Vigene Biosciences, a compatriot gene therapy CDMO specializing in viral vectors. The acquisition...
Charles River Laboratories has agreed to buy Cognate BioServices, a cell and gene therapy CDMO, for about $875 million. The purchase is expected to close by the end of...
04.02.2020
- Japanese drugmaker Takeda has entered into a multi-year drug discovery collaboration with contract research organization (CRO) Charles River. The companies, which have a long...
28.02.2018
- ChemSpec Europe 2018: The Fine and Specialty Chemicals exhibition, taking place 20 – 21 June 2018 at Koelnmesse in Cologne, Germany, is known for being a key marketplace for...
24.05.2017
- Chemspec Europe 2017 is just around the corner: The 32nd edition of the International Exhibition for Fine and Speciality Chemicals takes place from 31 May – 1 June 2017 at the...
12.05.2017
- Chemspec Europe 2017 is the International Exhibition for Fine and Speciality Chemicals. From 31 May – 1 June 2017, about 390 exhibitors from 29 countries will meet at the Munich...
